Increased local failure for patients with intermediate‐risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Increased local failure for patients with intermediate‐risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group

Published:2019-06-07 Issue:18 Volume:125 Page:3242-3248
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Casey Dana L.¹^ORCID,Chi Yueh‐Yun²,Donaldson Sarah S.³,Hawkins Douglas S.⁴^ORCID,Tian Jing²,Arndt Carola A.⁵,Rodeberg David A.⁶,Routh Jonathan C.⁷,Lautz Timothy B.⁸,Gupta Abha A.⁹^ORCID,Yock Torunn I.¹⁰,Wolden Suzanne L.¹

Affiliation:

1. Memorial Sloan Kettering Cancer Center New York New York

2. University of Florida Gainesville Florida

3. Stanford University School of Medicine Stanford California

4. Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington Seattle Washington

5. Mayo Clinic and Foundation Rochester Minnesota

6. East Carolina University Greenville North Carolina

7. Duke University School of Medicine Durham North Carolina

8. Northwestern University Chicago Illinois

9. Hospital for Sick Children Toronto Ontario Canada

10. Massachussets General Hospital Boston Massachusetts

Funder

St. Baldrick's Foundation

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32204

Reference28 articles.

1. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG 1 1For a complete list of the members of the Children’s Oncology Group Soft Tissue Sarcoma Committee (formerly Intergroup Rhabdomyosarcoma Group) representing the Children’s Oncology Group and the Quality Assurance Review Center, see the Appendix.

2. Effect of Radiotherapy Techniques (IMRT vs. 3D-CRT) on Outcome in Patients With Intermediate-Risk Rhabdomyosarcoma Enrolled in COG D9803—A Report From the Children’s Oncology Group

3. Preliminary Results of a Phase II Trial of Proton Radiotherapy for Pediatric Rhabdomyosarcoma

4. Is there a role for salvage re-irradiation in pediatric patients with locoregional recurrent rhabdomyosarcoma? Clinical outcomes from a multi-institutional cohort

5. Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ophthalmologic adverse events in childhood head and neck rhabdomyosarcoma survivors treated according to four different local treatment strategies;EJC Paediatric Oncology;2024-12

2. Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee;Pediatric Blood & Cancer;2024-09-03

3. The Prognostic Significance of Early Tumor Volume Change in Rhabdomyosarcoma;Advances in Radiation Oncology;2024-08

4. Randomised trials in children with rhabdomyosarcoma: time for a change?;The Lancet Oncology;2024-07

5. NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton Tumor;JCO Precision Oncology;2024-04